Company · CIK 0001823239 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
MARAVAI LIFESCIENCES HOLDINGS, INC. · MRVI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 FForm 4 → | Sep 9, 6:49 pm EDT | Bernd BrustChief Executive Officer, Director | 29,250 | $7.32 | $214,110 | 1,561,249 | — | |
| Aug 31, 2026 FForm 4 → | Sep 1, 6:21 pm EDT | Rajesh AsarpotaChief Financial Officer | 5,465 | $7.68 | $41,971 | 423,486 | — | |
| Aug 10, 2026 FForm 4 → | Aug 11, 4:44 pm EDT | Bernd BrustChief Executive Officer, Director | 29,250 | $6.23 | $182,228 | 1,590,499 | — | |
| Jul 30, 2026 FForm 4 → | Aug 3, 4:42 pm EDT | Rajesh AsarpotaChief Financial Officer | 5,465 | $6.59 | $36,014 | 428,951 | — | |
| Jul 8, 2026 FForm 4 → | Jul 10, 5:34 pm EDT | Bernd BrustChief Executive Officer, Director | 29,250 | $5.92 | $173,160 | 1,619,749 | — | |
| Jun 30, 2026 FForm 4 → | Jul 1, 8:30 pm EDT | Rajesh AsarpotaChief Financial Officer | 65,584 | $6.39 | $419,082 | 434,416 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.